The aim of the present study was to examine the dissolution of various preparations of calcium fluoride in inorganic solutions and in human saliva. Calcium fluoride was prepared by mixing either 0.25 or 0.02 mol/l calcium chloride with 0.5 or 0.04mol/l sodium fluoride. After preparation, the salts were washed in 1 mmol/l calcium chloride solution and in distilled water. A commercial product, calcium fluoride Suprapur® (Merck), was used for comparison. The solubility of the salts was examined in distilled water, in a 2-mmol/l sodium phosphate solution, and in whole human saliva, produced by chewing paraffin. It was found that the calcium fluoride ion product after suspension for 1–3 h in distilled water ranged closely around 10-10.7 for all salts. In the phosphate solution, the commercial product dissolved slowly, the ratio between dissolved fluoride and calcium ranged from 4 to 7, in buffered solutions approaching 2. The supernatant was not saturated by the salt. Our two calcium fluoride salts dissolved quickly and made the phosphate-containing solutions supersaturated with respect to fluorapatite, leading to fluorapatite formation, and because of compensating calcium fluoride dissolution, this led to increasing fluoride concentrations in saliva of up to around 85-95 ppm. The results of this study indicate that calcium fluoride of less than Suprapur standard may dissolve quickly in saliva, unless the dissolution is retarded by a physical barrier, like a forming pellicle.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.